IQVIA Holdings Inc
IQV185.860USD
-5.680-2.97%
Close 07/31, 16:00（ET）Quotes delayed by 15 min
31.60BMarket Cap
23.69P/E TTM
More Details of IQVIA Holdings Inc Company
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Company Info
Ticker SymbolIQV
Company nameIQVIA Holdings Inc
IPO dateMay 09, 2013
Founded at2016
CEOMr. Ari Bousbib
Number of employees88000
Security typeOrdinary Share
Fiscal year-endMay 09
Address2400 Ellis Road
CityDURHAM
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code27703
Phone19199982000
Websitehttps://ir.iqvia.com/
Ticker SymbolIQV
IPO dateMay 09, 2013
Founded at2016
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
+0.75%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
7.01K
+17.56%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
2.74K
+157.67%
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
--
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
863.00
-8.87%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
+0.75%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
Americas
1.81B
47.19%
Europe & Africa Region
1.22B
31.97%
Asia Pacific Region
798.00M
20.84%
By Business
By Region
No Data
Shareholding Stats
Updated: Thu, Jul 24
Updated: Thu, Jul 24
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.62%
Harris Associates L.P.
6.57%
BlackRock Institutional Trust Company, N.A.
5.81%
State Street Global Advisors (US)
4.54%
GIC Private Limited
3.85%
Other
67.60%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.62%
Harris Associates L.P.
6.57%
BlackRock Institutional Trust Company, N.A.
5.81%
State Street Global Advisors (US)
4.54%
GIC Private Limited
3.85%
Other
67.60%
Shareholder Types
Shareholders
Proportion
Investment Advisor
45.68%
Investment Advisor/Hedge Fund
31.75%
Hedge Fund
6.56%
Sovereign Wealth Fund
4.94%
Pension Fund
4.66%
Research Firm
2.37%
Bank and Trust
2.16%
Individual Investor
0.91%
Family Office
0.10%
Other
0.88%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
2044
168.82M
99.30%
-7.45M
2025Q1
2083
168.53M
97.38%
-9.36M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
2023Q3
1925
170.01M
92.82%
-4.41M
2023Q2
1898
167.84M
91.62%
-8.26M
2023Q1
1870
169.28M
91.24%
-7.20M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
19.76M
11.42%
-293.38K
-1.46%
Mar 31, 2025
Harris Associates L.P.
11.17M
6.46%
-166.29K
-1.47%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
9.88M
5.71%
-196.58K
-1.95%
Mar 31, 2025
State Street Global Advisors (US)
7.72M
4.46%
-157.55K
-2.00%
Mar 31, 2025
GIC Private Limited
6.54M
3.78%
-2.59M
-28.36%
Mar 31, 2025
CPP Investment Board
4.59M
2.66%
+312.81K
+7.31%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.24M
2.45%
+59.53K
+1.43%
Mar 31, 2025
AllianceBernstein L.P.
3.54M
2.04%
-57.68K
-1.60%
Mar 31, 2025
Farallon Capital Management, L.L.C.
3.41M
1.97%
+288.70K
+9.24%
Mar 31, 2025
Capital Research Global Investors
2.13M
1.23%
+589.82K
+38.40%
Mar 31, 2025
View more
Related ETFs
Updated: Sun, Jul 6
Updated: Sun, Jul 6
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
6.05%
VanEck Biotech ETF
3.83%
Global X HealthTech ETF
3.58%
Langar Global HealthTech ETF
2.7%
iShares Biotechnology ETF
2.58%
American Century Focused Large Cap Value ETF
2.11%
American Century Mid Cap Growth Impact ETF
2.05%
Running Oak Efficient Growth ETF
1.7%
Invesco Zacks Mid-Cap ETF
1.59%
Fidelity Digital Health ETF
1.52%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion6.05%
VanEck Biotech ETF
Proportion3.83%
Global X HealthTech ETF
Proportion3.58%
Langar Global HealthTech ETF
Proportion2.7%
iShares Biotechnology ETF
Proportion2.58%
American Century Focused Large Cap Value ETF
Proportion2.11%
American Century Mid Cap Growth Impact ETF
Proportion2.05%
Running Oak Efficient Growth ETF
Proportion1.7%
Invesco Zacks Mid-Cap ETF
Proportion1.59%
Fidelity Digital Health ETF
Proportion1.52%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
